![logo](/logos/AORT.webp)
Artivion, Inc.
NYSE:AORT
25.11 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Artivion, Inc. |
Symbool | AORT |
Munteenheid | USD |
Prijs | 25.11 |
Beurswaarde | 1,051,945,785 |
Dividendpercentage | 0% |
52-weken bereik | 12.16 - 29.24 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. James Patrick Mackin |
Website | https://artivion.com |
An error occurred while fetching data.
Over Artivion, Inc.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)